In total, 18 companies and two top executives, including Mylan's president, are now named in the complaint. Mylan's …
Lawmakers seethed, parents broke into tears at pharmacy counters, regulators opened investigations, competitors raced to come up with cheaper alternatives, and Mylan’s stock tumbled 29 percent. Further Reading Rage mounts against …
It noted that the company's market capitalization has swelled to more than $20 million from about $3 million over the last 15 years, and its stock price also has soared over the longer time frame. "During Mr. Coury's long tenure, Mylan has …
The generic drug company's move is a blow to the Tel Aviv Stock Exchange's recovery prospects. Generic drugs company Mylan has announced its intention of delisting from the Tel Aviv Stock Exchange. Mylan has been traded in Tel Aviv …
Mylan NV shares rose 2.8% in premarket trade Tuesday after the company reported a first-quarter profit beat and revenue miss. Earnings for the latest quarter rose to $66.4 million, or 12 cents per share, from $13.9 million, or 3 cents per …
During the public outcry that followed, CEO Heather Bresch was called to testify before Congress in fall 2016 and Mylan's stock price was hammered. Still, the price of an EpiPen didn't change, and Chairman and former CEO Robert Coury …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports. Mylan's stock plunged after the maker of Epi …
Mylan N.V. MYL is scheduled to report first-quarter 2017 results on May 10, before the market opens. The company’s performance has been mixed so far, having beaten earnings estimates in three of the trailing four quarters and missing …
* Mylan NV - ‍announced it is voluntarily delisting company’s ordinary shares from trading on tel aviv stock exchange * Mylan NV - ‍ delisting of Mylan’s ordinary shares from tase will become effective in three months, on February 12, 2018 ...